First‑Line Antibiotic Prophylaxis for Neuro‑Surgical Procedures
General Recommendations
Cefazolin 2 g administered by slow IV infusion is the first‑line agent for prophylaxis of neuro‑surgical infections. It should be given as a single dose 30 minutes before skin incision, with an intra‑operative re‑dose of 1 g if the procedure exceeds 4 hours. Strong recommendation (Grade A)【1】【2】【3】【4】【5】
Prophylaxis should be limited to the operative period; a single pre‑operative dose is sufficient for most cases, and extending therapy beyond 48 hours is prohibited. Strong recommendation (Grade A)【1】【2】【3】【5】
Procedure‑Specific Regimens
Craniotomy (with or without prosthetic material)
- Cefazolin 2 g IV slow infusion as a single pre‑operative dose, with a repeat 1 g dose if surgery lasts >4 h; the prophylaxis is confined to the intra‑operative window. Strong recommendation (Grade A)【1】【2】【3】【4】【5】
Cerebrospinal‑Fluid (CSF) Shunt Placement
- Cefazolin 2 g IV slow infusion as a single pre‑operative dose, re‑dosed 1 g if >4 h. Prophylaxis significantly reduces infection risk in craniotomy and likely reduces risk in shunt insertion. Strong recommendation (Grade A)【1】【6】【7】
Spinal Surgery with Prosthetic Implant
- Cefazolin 2 g IV slow infusion, re‑dosed 1 g for procedures >4 h. Strong recommendation (Grade A)【1】【6】【7】
Trans‑sphenoidal and Trans‑labyrinthine Neurosurgery
- Cefazolin 2 g IV slow infusion, re‑dosed 1 g if operative time exceeds 4 h. Strong recommendation (Grade A)【1】【2】【3】【4】
Cranio‑facial Wounds (open head injuries)
- Aminopenicillin + β‑lactamase inhibitor (2 g IV slow infusion), administered 2 g every 8 h, with a maximum duration of 48 h to ensure coverage of anaerobic flora. Strong recommendation (Grade A)【1】【2】【3】【4】
Alternative Regimen for β‑Lactam Allergy
Vancomycin 30 mg/kg IV infused over 120 minutes is the first‑line alternative for patients with β‑lactam allergy. Strong recommendation (Grade A)【1】【2】【3】【4】【5】
Indications for vancomycin prophylaxis include:
Timing and Duration
Antibiotic prophylaxis must be initiated within 30 minutes before incision; the injection should be separated by 5–10 minutes from anesthetic agents to allow detection of allergic reactions. Strong recommendation (Grade A)【5】
Vancomycin infusion must be started early enough to finish at least 30 minutes before the first incision. Strong recommendation (Grade A)【1】【2】【3】【4】【5】
Intra‑operative re‑dosing (e.g., cefazolin 1 g) is advised when surgery exceeds 4 hours to maintain adequate tissue concentrations. Strong recommendation (Grade A)【2】【3】【5】
Target Pathogens
Enterobacteriaceae – especially relevant after craniotomies. Strong recommendation (Grade A)【1】【8】【6】【7】
Staphylococci (S. aureus, S. epidermidis) – common skin flora implicated in neurosurgical infections. Strong recommendation (Grade A)【1】【8】【6】【7】
Anaerobic bacteria – particularly after cranio‑facial wounds. Strong recommendation (Grade A)【1】【8】【6】【7】
Evidence of Efficacy
Prophylactic antibiotics unequivocally reduce infection rates in craniotomy (risk without prophylaxis 1–5 %; with prophylaxis markedly lower). Strong recommendation (Grade A)【1】【2】【3】【4】【5】
CSF shunt procedures carry an infection risk of ≈10 % without prophylaxis, which is mitigated by cefazolin administration. Strong recommendation (Grade A)【1】【6】【7】【2】
Special Situations
No prophylaxis is recommended for external CSF shunts or for basal skull fractures with CSF rhinorrhoea. Strong recommendation (Grade A)【1】【2】【3】【4】
Patients colonised with MRSA undergoing procedures that involve prosthetic material should receive vancomycin in addition to cefazolin. Strong recommendation (Grade A)【1】
Practical Considerations
Avoid unnecessary prolongation of prophylaxis; extended courses do not prevent infection and promote antimicrobial resistance. Strong recommendation (Grade A)【2】【3】
Separate antibiotic administration from anesthetic drugs by 5–10 minutes to identify possible allergic reactions. Strong recommendation (Grade A)【5】
Maintain effective tissue concentrations throughout the operation; intra‑operative re‑dose is advised when indicated. Strong recommendation (Grade A)【2】【3】【5】
Adapt recommendations to local microbiological ecology and resistance patterns. Strong recommendation (Grade A)【1】【2】【3】【4】【5】
Prophylactic Antibiotic Use in Cranial Surgery
Standard Prophylaxis Duration
- A single pre‑operative dose of cefazolin (2 g IV given 30–60 min before incision) is sufficient for the majority of cranial procedures; routine extension of prophylaxis beyond the operative period is not supported by evidence. Evidence level: high [9][10]
- Antibiotic prophylaxis should be strictly limited to the intra‑operative period and stopped immediately after skin closure. Evidence level: high [9][10]
- Intra‑operative redosing of cefazolin (1 g IV) is required only when the operation lasts longer than 4 hours or estimated blood loss exceeds 1.5 L. Evidence level: moderate [9][10]
- Extending prophylaxis beyond 24 hours does not further reduce surgical‑site infection (SSI) rates and adds unnecessary risk of antibiotic‑related complications. Evidence level: high [9][10]
Situations Requiring Therapeutic (Not Prophylactic) Antibiotics
- Therapeutic antibiotics are indicated solely for treatment of an established infection, not for prophylaxis. Evidence level: high 11
- Clinical signs that mandate therapeutic therapy include fever, wound erythema extending >5 cm from the incision, purulent drainage, or a white‑blood‑cell count >12 000 µL⁻¹. Evidence level: high 12
- Positive microbiologic cultures from the surgical site or cerebrospinal fluid confirm infection and require therapeutic treatment. Evidence level: high 11
Empiric Management of Confirmed Infections
- Before starting antibiotics, obtain blood and CSF cultures (and wound cultures when feasible) in critically ill patients. Evidence level: high 11
- Empiric broad‑spectrum regimens should cover Staphylococcus aureus (including methicillin‑susceptible strains), coagulase‑negative Staphylococcus, and Gram‑negative organisms. Evidence level: moderate 13
- Daily reassessment of antibiotic choice, spectrum, and duration is recommended to ensure appropriateness. Evidence level: high 11
Harms of Unnecessary Prophylaxis Extension
- Prolonged prophylaxis does not lower SSI incidence (relative risk 1.04; 95 % CI 0.85–1.27). Evidence level: high 9
- Unnecessary antibiotic exposure increases the risk of Clostridioides difficile infection, promotes antimicrobial resistance, and raises healthcare costs. Evidence level: high 10
Immediate Post‑operative Practice
- Discontinue all prophylactic antibiotics immediately after surgery; no postoperative doses are required in the absence of infection. Evidence level: high [9][10]
Key Takeaway: The only valid indication for extending antibiotics beyond the operative period after cranial surgery is the presence of a confirmed infection that requires therapeutic treatment; routine prophylactic extension offers no benefit and may cause harm.